statistiche ricercatore

VISCA, DINA

Distribuzione geografica

Continente	#
NA - Nord America	7.336
EU - Europa	3.040
AS - Asia	2.973
SA - Sud America	384
Continente sconosciuto - Info sul continente non disponibili	361
AF - Africa	85
OC - Oceania	13
Totale	14.192

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	7.192
IT - Italia	1.609
SG - Singapore	1.102
CN - Cina	610
HK - Hong Kong	434
VN - Vietnam	407
BR - Brasile	308
UA - Ucraina	286
IE - Irlanda	195
DE - Germania	177
SE - Svezia	156
GB - Regno Unito	147
BD - Bangladesh	137
FR - Francia	135
RU - Federazione Russa	105
TR - Turchia	81
FI - Finlandia	65
MX - Messico	59
CA - Canada	58
AT - Austria	49
JP - Giappone	35
AR - Argentina	34
IN - India	31
NG - Nigeria	27
IQ - Iraq	23
ZA - Sudafrica	23
ES - Italia	22
ID - Indonesia	21
NL - Olanda	20
PL - Polonia	17
CL - Cile	14
PK - Pakistan	14
AU - Australia	12
CZ - Repubblica Ceca	12
MY - Malesia	12
PH - Filippine	9
SA - Arabia Saudita	9
IR - Iran	7
LT - Lituania	7
RO - Romania	7
EC - Ecuador	6
VE - Venezuela	6
AE - Emirati Arabi Uniti	5
EG - Egitto	5
EU - Europa	5
SK - Slovacchia (Repubblica Slovacca)	5
CR - Costa Rica	4
HN - Honduras	4
JM - Giamaica	4
JO - Giordania	4
KE - Kenya	4
KZ - Kazakistan	4
MA - Marocco	4
MD - Moldavia	4
NP - Nepal	4
OM - Oman	4
PT - Portogallo	4
PY - Paraguay	4
TN - Tunisia	4
TT - Trinidad e Tobago	4
UY - Uruguay	4
AL - Albania	3
BE - Belgio	3
CO - Colombia	3
DZ - Algeria	3
GT - Guatemala	3
HU - Ungheria	3
PE - Perù	3
SN - Senegal	3
UZ - Uzbekistan	3
AZ - Azerbaigian	2
BH - Bahrain	2
BO - Bolivia	2
CH - Svizzera	2
DK - Danimarca	2
GN - Guinea	2
KH - Cambogia	2
LK - Sri Lanka	2
SV - El Salvador	2
TH - Thailandia	2
ZM - Zambia	2
A2 - ???statistics.table.value.countryCode.A2???	1
AM - Armenia	1
BB - Barbados	1
BN - Brunei Darussalam	1
BY - Bielorussia	1
CI - Costa d'Avorio	1
CU - Cuba	1
CY - Cipro	1
ET - Etiopia	1
GA - Gabon	1
GD - Grenada	1
GE - Georgia	1
GR - Grecia	1
KG - Kirghizistan	1
KN - Saint Kitts e Nevis	1
LY - Libia	1
ML - Mali	1
MU - Mauritius	1
MZ - Mozambico	1
Totale	13.828

Salva come PNG Salva come JPEG

Città	#
Milan	1.047
Fairfield	746
Ashburn	720
San Jose	610
Singapore	589
Hong Kong	428
Woodbridge	352
Chandler	337
Houston	311
Seattle	287
Wilmington	286
Cambridge	279
Jacksonville	271
Council Bluffs	253
Dallas	204
Beijing	198
Dublin	190
Princeton	182
The Dalles	164
Ann Arbor	134
Chicago	125
New York	124
Boardman	123
Lauterbourg	112
Nyköping	99
Rome	96
Dearborn	93
Dong Ket	89
Ho Chi Minh City	89
Los Angeles	87
San Diego	78
Santa Clara	73
London	67
Izmir	62
Hanoi	51
Helsinki	51
Ogden	45
Munich	44
Mexico City	43
São Paulo	39
Nuremberg	30
Vienna	30
Abuja	27
Salt Lake City	25
San Francisco	25
Tokyo	25
Orem	24
Frankfurt am Main	22
Phoenix	22
Redmond	21
Washington	21
San Genesio Ed Uniti	19
Atlanta	18
Toronto	18
Como	17
Brooklyn	15
Buffalo	15
Guangzhou	15
Shanghai	15
Tampa	15
Norwalk	14
Warsaw	14
Haiphong	13
Hangzhou	13
Montreal	13
Elk Grove Village	12
Hefei	12
Belo Horizonte	11
Brno	11
Chennai	11
Johannesburg	11
Kunming	11
Varese	11
Baghdad	10
Dhaka	9
Pavia	9
Stockholm	9
Cedar Knolls	8
Columbus	8
Denver	8
Jakarta	8
Kilburn	8
Kuala Lumpur	8
Lancaster	8
Magnago	8
Naples	8
Rio de Janeiro	8
Biên Hòa	7
Charlotte	7
Falkenstein	7
Manchester	7
Memphis	7
Miami	7
Monza	7
Amsterdam	6
Boston	6
Cape Town	6
Da Nang	6
Florence	6
Lappeenranta	6
Totale	9.956

Salva come PNG Salva come JPEG

Nome	#
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases	331
Adverse Reactions to Food: Allergies and Intolerances	271
Classifying new anti-tuberculosis drugs: rationale and future perspectives	251
Adherence to Continuous Positive Airway Pressure in patients with Obstructive Sleep Apnoea. A ten year real life study	232
Airway inflammatory phenotypes: Making sputum cell evaluation more accessible for clinical use	213
Effectiveness of pulmonary rehabilitation in severe asthma: a retrospective data analysis	205
When kidneys and lungs suffer together	201
Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae	194
Tuberculosis elimination: Where are we now?	184
Intestine: Organ or Apparatus?	181
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial	180
Cardiovascular function in pulmonary emphysema	178
Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients	177
Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial	176
Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation.	175
Is bronchodilator the correct treatment for COPD subjects before EBUS?	173
Classification of Malabsorption Syndromes	169
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases	169
Ambulatory oxygen in interstitial lung disease	167
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD	163
Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery	163
Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler	160
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis	159
Relationship between diabetes and respiratory diseases—Clinical and therapeutic aspects	156
Ventilatory response to carbon dioxide output in subjects with congestive heart failure and in patients with COPD with comparable exercise capacity	155
Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: A systematic review	154
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: a global feasibility study	152
Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns	151
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis	149
Care-Related intervention in Rehabilitative Pneumology: Pulmonary Rehabilitation in Chronic Obstructive Broncopneumopathies (COPD) can benefit from a multidisciplinary approach? [Cure correlate in Pneumologia Riabilitativa: La Riabilitazione Polmonare nelle Broncopneumopatie Croniche Ostruttive (BPCO) può trarre beneficio da un approccio multidisciplinare?]	145
World TB Day 2017: Strengthening the fight against TB	144
Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night	143
Eligibility for the shorter regimen for multidrug-resistant tuberculosis in Mexico	143
The 5-repetition sit-to-stand test as an outcome measure for pulmonary rehabilitation in subjects with asthma	143
Fecal calprotectin concentrations in alcoholic patients: A longitudinal study	142
Electrocardiographic features of patients with COVID-19 pneumonia	141
Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine	140
Evolution of programmatic definitions used intuberculosis prevention and care	139
Is Two Better Than One? The Impact of Doubling Training Volume in Severe COPD: A Randomized Controlled Study	137
Minimal clinically important difference of the 6-min walking test in patients with asthma	136
Functional impairment during post-acute COVID-19 phase: Preliminary finding in 56 patients	134
Multi and extensively drug-resistant pulmonary tuberculosis: Advances in diagnosis and management	132
A snapshot of exhaled nitric oxide and asthma characteristics: experience from high to low income countries	132
Pulmonary Rehabilitation and Asthma	128
The role of blood gas analysis in the post-acute phase of COVID-19 pneumonia	126
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts	124
Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study	123
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network	119
Combined use of electrocardiography and ultrasound to detect cardiac and pulmonary involvement after recovery from COVID-19 pneumonia: A case series	119
Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia. Authors' reply	117
Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations	116
Effectiveness of a Pulmonary Rehabilitation Program on Persistent Asthma Stratified for Severity	112
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment	111
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: First global report	109
Chronic cough in adults	109
Severity of COVID-19: The importance of being hypertensive	108
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact	108
Analysis of Patients with Asthma and Mixed Granulocytic Inflammatory Pattern in Sputum	107
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression	103
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy	103
SARS-CoV-2 vaccines: Lights and shadows	102
Something is changing in adherence to CPAP therapy: Real world data after 1 year of treatment in patients with obstructive sleep apnoea	101
Effects of biological therapies on chronic rhinosinusitis in severe asthmatic patients	101
Pulmonary rehabilitation in patients recovering from COVID-19	99
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment	98
Post tuberculosis treatment infectious complications	97
Tuberculosis and COVID-19 co-infection: description of the global cohort	97
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects	95
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort	93
Cost-effectiveness of ambulatory oxygen in improving quality of life in fibrotic lung disease: Preliminary evidence from the AmbOx Trial	92
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease	92
Pulmonary rehabilitation: Promising nonpharmacological approach for treating asthma?	90
Pulmonary rehabilitation in patients with interstitial lung diseases: Correlates of success	89
Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19	89
Post-TB disease: a new topic for investigation-and why it matters	88
High-flow oxygen therapy during exercise training in patients with chronic obstructive pulmonary disease and chronic hypoxemia: A multicenter randomized controlled trial	87
Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial	87
Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry	87
Severe asthma: One disease and multiple definitions	87
Alpha-1 deficiency in severe asthma patients	84
Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)	83
Brazilian Thoracic Association recommendations for the management of post-tuberculosis lung disease	82
Epidemic and pandemic viral infections: Impact on tuberculosis and the lung	82
A systematic review of the costs of diagnosis for multidrug-resistant/extensively drug-resistant TB in different settings	81
Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease	80
Rehabilitation, optimized nutritional care, and boosting host internal milieu to improve long-term treatment outcomes in tuberculosis patients	79
Time course of exercise capacity in patients recovering from covid-19-associated pneumonia	79
Post-tuberculosis lung disease: a comparison of Brazilian, Italian, and Mexican cohorts	79
History of prevention, diagnosis, treatment and rehabilitation of pulmonary sequelae of tuberculosis	78
Effect of pulmonary rehabilitation on heart rate recovery in adult individuals with asthma or chronic obstructive pulmonary disease	77
Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease	77
An overview of Cochrane systematic reviews for pulmonary rehabilitation interventions in people with chronic obstructive pulmonary disease: a mapping synthesis	75
Management of chronic refractory cough in adults	74
Current developments and future directions in COPD	72
Tuberculosis in the time of COVID-19: quality of life and digital innovation	71
Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence	71
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life	71
The Maugeri daily activity profile: A tool to assess physical activity in patients with chronic obstructive pulmonary disease	71
Correction to: When kidneys and lungs suffer together (Journal of Nephrology, (2019), 32, 5, (699-707), 10.1007/s40620-018-00563-1)	70
Heart rate recovery in adult individuals with asthma	69
Totale	12.658

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	74.656
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	74.656

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	823	0	27	64	11	33	63	85	72	58	244	69	97
2022/2023	1.055	102	82	104	132	58	227	6	109	133	49	21	32
2023/2024	1.808	248	259	245	301	374	154	72	18	75	39	6	17
2024/2025	1.880	20	25	281	50	74	140	67	76	237	275	176	459
2025/2026	4.508	314	272	247	485	312	221	1.020	288	495	293	287	274
2026/2027	356	156	200	0	0	0	0	0	0	0	0	0	0
Totale													14.192